Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
<p>Abstract</p> <p>Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2001-07-01
|
| Col·lecció: | Current Controlled Trials in Cardiovascular Medicine |
| Matèries: | |
| Accés en línia: | http://cvm.controlled-trials.com/content/2/4/171 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|